NeuroSense Therapeutics granted US patent protection for use of PrimeC combination in Alzheimer's disease

LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus

HistoIndex partners Houston Research Institute

Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea

Eli Lilly agrees to acquire Ventyx Biosciences

Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial

Hoth Therapeutics files two US provisional patent applications to establish oncology-focused dermatology platform

Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis

Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA

Alvotech launches first-in-market golimumab biosimilar in Europe

Physiomics secures follow-on UK contract for Phase 2 study support

RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL

InduPro secures strategic investment and collaboration with Sanofi to advance autoimmune therapy

Innovent Biologics reports first participant dosed in Phase 1 trial of IBI3011